Pharmaceuticals Novartis Announces the Pivotal Phase III APPLY-PNH trialBy AndyOctober 25, 20220 Novartis investigational oral monotherapy iptacopan demonstrates clinically meaningful superiority over anti-C5 treatment in Pivotal Phase III APPLY-PNH trial Novartis has…
